A carregar...

AAV-based Neonatal Gene Therapy for Hemophilia A: Long-Term Correction and Avoidance of Immune Responses in Mice

Hemophilia A gene therapy has been hampered by immune responses to vector-associated antigens and by neutralizing antibodies or inhibitors to the factor VIII (FVIII) protein; these ‘inhibitors’ more commonly effect hemophilia A patients than those with hemophilia B. A gene replacement strategy begin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hu, Chuhong, Lipshutz, Gerald S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3432168/
https://ncbi.nlm.nih.gov/pubmed/22241178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2011.200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!